Sunday ،Oct 26, 2025، 22:11

News

Decision-Making Session Held to Launch Procurement Process for Selected Medical Equipment Vendors
As part of the implementation of a joint memorandum of understanding between the Food and Drug Administration and the Medical Procurement
20 October 2025
Formulation of Operational Guidelines for Strategic Drug Stockpiling at the MPO
In a specialized meeting held on Saturday, October 18, 2025, attended by Dr. Mohammadreza Shanehsaz, Managing Director of the Medical Procurement
19 October 2025
Red Crescent Medical Equipment Sales Surge by 67%
The Medical Equipment Division of the Red Crescent’s Medical Procurement Organization has achieved a remarkable 67% increase in sales by the end of
15 October 2025
Enhancing Pharmaceutical Coordination Between the MPO and the FDA to Strengthen National Preparedness
In a joint meeting of senior officials from the Medical Procurement Organization and the Food and Drug Administration, practical strategies were
9 October 2025
Enhancing Pharmaceutical Collaboration: Joint Meeting Between 13 Aban and 29 Farvardin Pharmacies and the Medical Procurement
In a joint meeting attended by the directors of the 13 Aban and 29 Farvardin pharmacies and the CEO of the Medical Procurement Organization, avenues
7 October 2025
32% Surge in Prescription Intake at Red Crescent Pharmacies in September 2025
The Central, Subspecialty, and Tehranpars pharmacies of the Iranian Red Crescent Society, affiliated with the Medical Procurement Organization,
5 October 2025
1

Medical News

The World Health Organization (WHO), in collaboration with the Swiss Tropical and Public Health Institute (Swiss TPH), has unveiled the updated 2025 Air Quality Standards database. This resource compiles national air quality standards for major pollutants and other airborne toxics from countries worldwide. This latest update provides an overview of global efforts towards achieving the WHO global air quality guidelines, with 17% more countries now implementing standards for pollutants that pose a risk to human health.
WHO announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine product, Cecolin® has been confirmed for use in a single-dose schedule.
1

Photo Gallery

نقشه جدید